| Active Not Recruiting | PMT for MDRO Decolonization NCT05632315 | University of Pennsylvania | Phase 2 |
| Recruiting | FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae NCT05791396 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Phase 1 / Phase 2 |
| Recruiting | Fecal Transplantation to Eradicate Colonizing Emergent Superbugs NCT05035342 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Unknown | Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resis NCT05516433 | Fondation Hôpital Saint-Joseph | — |
| Withdrawn | PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections NCT05355350 | Rambam Health Care Campus | Phase 4 |
| Completed | Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. NCT04276480 | University Hospital, Bordeaux | N/A |
| Completed | Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic NCT05055479 | Centre Hospitalier Universitaire, Amiens | — |
| Unknown | Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae NCT04903886 | University Hospital, Brest | — |
| Unknown | Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLIC NCT04836208 | Institut Pasteur | — |
| Recruiting | FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae NCT04759001 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Phase 1 / Phase 2 |
| Unknown | Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics NCT03967301 | Hospital Italiano de Buenos Aires | N/A |
| Completed | ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTE NCT07172932 | Ankara City Hospital Bilkent | — |
| Withdrawn | Pilot Study Using Oral Capsule FMT to Decolonize GI CRE NCT03527056 | University of California, Los Angeles | EARLY_Phase 1 |
| Completed | Community-associated Highly-Resistant Enterobacterales NCT03924934 | University of North Carolina, Chapel Hill | — |
| Recruiting | PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resis NCT03671967 | Rambam Health Care Campus | Phase 4 |
| Suspended | Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae NCT03891433 | Universidad del Norte | Phase 4 |
| Completed | Prevalence of ESBL and CPE in French Nursing Homes NCT03401242 | Nantes University Hospital | — |
| Unknown | The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers NCT03411590 | FrieslandCampina WAMCO Nigeria PLC | N/A |
| Completed | Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit NCT04528043 | Central Hospital, Nancy, France | — |
| Completed | Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the C NCT03477084 | Centre Hospitalier Universitaire de Besancon | — |
| Completed | Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacter NCT02795949 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 3 |
| Completed | Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly Fr NCT02482051 | Denver Health and Hospital Authority | — |
| Unknown | 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection NCT02450942 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Completed | Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae NCT02400268 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 3 |
| Completed | Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study NCT00826670 | University Hospital, Geneva | Phase 4 |
| Completed | The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Tai NCT01725841 | National Taiwan University Hospital | — |
| Unknown | The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Chil NCT00894036 | University Hospital, Geneva | — |
| Completed | Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organ NCT00573521 | University of Pittsburgh | — |
| Completed | Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli NCT00573235 | University of Pittsburgh | — |
| Unknown | Infections Caused by ESbL-Producing Enterobacteriaceae in Italy NCT00404625 | University of Siena | — |